Encompass Health raises 2026 outlook to $6.45B-$6.5B revenue as it targets $20M-$24M pre-opening costs while expanding capacity (NYSE:EHC)

Encompass Health Corp (EHC) raised its 2026 guidance, reporting Q3 revenue growth of 8.9%, adjusted EBITDA up 15.5%, and adjusted EPS up 23.6%. The company expanded capacity with new hospitals and beds, while noting challenges like bad debt and regulatory uncertainty. Management expects strong performance in 2027, with continued capacity additions and managed care pricing improvements.

Encompass Health (EHC) reported Q3 2026 revenue growth of 8.9%, adjusted EBITDA up 15.5%, and adjusted EPS up 23.6%. The company raised its 2026 guidance and highlighted strong patient outcomes and industry recognition. It opened new hospitals and added beds, with a pipeline of 15 new hospitals. Q3 bad debt expense was 2.7%, expected to normalize. Adjusted EBITDA was $346.6 million, with net provider tax contribution revised to $3 million for 2026.

Encompass Health reported Q3 2026 revenue of $1.61B, up 8.9%, and adjusted EBITDA of $346.6M, up 15.5%. Adjusted EPS grew 23.6% to $1.52. The company raised full-year guidance for revenue, EBITDA, and EPS. Growth was driven by higher discharge volumes and increased net revenue per discharge. The company is expanding capacity and prioritizing North Carolina markets post-regulatory changes.

Encompass Health (EHC) reported Q3 2026 revenue growth of 8.9%, adjusted EBITDA up 15.5%, and EPS up 23.6%. The company raised its full-year guidance, citing strong operational momentum. Shares rose 5.67% post-earnings.

Encompass Health (EHC) reported Q3 2026 net operating revenue of $1.61B, up 8.9% YoY, and raised full-year guidance. Adjusted EPS of $1.52 beat estimates by 11.9%. Shares rose 4.7% on the news, setting a new 52-week high at $128.63.

Encompass Health (EHC) reported Q3 2026 revenue of $1.61B, up 8.9% YoY, beating estimates. Adjusted EPS of $1.52 exceeded expectations. The company raised full-year guidance. Shares fell 2.9% post-results.